Medpace Holdings Inc (MEDP) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Total Assets Chart for Medpace Holdings Inc
Medpace Holdings Inc (MEDP) total assets for FY2025 were USD 2.0B, a -6.0% change from FY2024. Medpace Holdings Inc's total assets grew from USD 1.1B in 2014 to USD 2.0B in 2025 (80.1% over 11 years). Total assets compound annual growth rate: 5-year CAGR of 7.3%, 10-year CAGR of 7.2%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $16.83B
- Implied Share Price
- $602.90
- Enterprise Value
- $16.84B
- Revenue (TTM)
- $2.78B
- EBITDA
- $611.20M
- Profit Margin
- 17.67%
- Trailing P/E
- 35.40
- Forward P/E
- 31.95
- Price/Book (MRQ)
- 39.70
- Price/Sales (TTM)
- 6.05
- EV/EBITDA
- 27.56
- EV/Revenue
- 6.05
- Dividend Yield
- —
- Book Value
- $15.54
- Free Cash Flow (FY2025)
- $681.87M
- Free Cash Flow Yield
- 4.05%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.